Veliter at Tides China Digital Event: Trends in Oligonucleotide Synthesis and Manufacturing
Event: Trends in Oligonucleotide Synthesis and Manufacturing
Date: June 13th, 2024，9:00 AM – 12:05 PM CST (China Standard Time)
Location: Digital Event
Veliter’s Topic: Quality Control/Process Development/Manufacturing of Oligonucleotide API(DS)
Time: 11:35-12:05
Speaker: Alex Xu – CEO & Founder of Veliter
Reviewing of oligonucleotide drugs (ASO, siRNA, Aptamer, miRNA, sgRNA, etc.) including catalog, drugable advantage and current market reality, this presentation will focus on the challenge of oligo production in the terms of analytical development and qualification/validation, impurities analysis and control, and quality control of long oligonucleotide production, and introduction of Veliter with one-stop oligo CDMO solutions from preclinical to commercial.
Reference: https://www.cytivalifesciences.com/en/us